| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO).
|
Blood
|
2001
|
2.48
|
|
2
|
Bone marrow transplantation for paroxysmal nocturnal hemoglobinuria.
|
Haematologica
|
2000
|
1.66
|
|
3
|
Quality of life in 244 recipients of allogeneic bone marrow transplantation.
|
Br J Haematol
|
2000
|
1.55
|
|
4
|
Pre-emptive therapy of acute graft-versus-host disease: a pilot study with antithymocyte globulin (ATG).
|
Bone Marrow Transplant
|
2001
|
1.39
|
|
5
|
Increased risk of leukemia relapse with high-dose cyclosporine A after allogeneic marrow transplantation for acute leukemia.
|
Blood
|
1991
|
1.36
|
|
6
|
Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain.
|
Blood
|
2001
|
1.24
|
|
7
|
Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD.
|
Bone Marrow Transplant
|
2008
|
1.20
|
|
8
|
Factors influencing haematological recovery after allogeneic haemopoietic stem cell transplants: graft-versus-host disease, donor type, cytomegalovirus infections and cell dose.
|
Br J Haematol
|
2001
|
1.14
|
|
9
|
Reduced intensity thiotepa-cyclophosphamide conditioning for allogeneic haemopoietic stem cell transplants (HSCT) in patients up to 60 years of age.
|
Br J Haematol
|
2000
|
1.09
|
|
10
|
Hairy cell leukemia: a clinical review based on 725 cases of the Italian Cooperative Group (ICGHCL). Italian Cooperative Group for Hairy Cell Leukemia.
|
Leuk Lymphoma
|
1994
|
1.00
|
|
11
|
Cytogenetic abnormalities in patients with severe aplastic anemia.
|
Haematologica
|
1997
|
0.95
|
|
12
|
Conventional hematopoietic stem cell transplants from identical or alternative donors are feasible in recipients relapsing after an autograft.
|
Haematologica
|
2001
|
0.94
|
|
13
|
ABO-incompatible bone marrow transplantation: a GITMO survey of current practice in Italy and comparison with the literature.
|
Bone Marrow Transplant
|
2004
|
0.92
|
|
14
|
Pre-emptive treatment of acute GVHD: a randomized multicenter trial of rabbit anti-thymocyte globulin, given on day+7 after alternative donor transplants.
|
Bone Marrow Transplant
|
2009
|
0.91
|
|
15
|
In vivo B-cell depletion with rituximab for alternative donor hemopoietic SCT.
|
Bone Marrow Transplant
|
2011
|
0.91
|
|
16
|
Prophylactic antithymocyte globulin reduces the risk of chronic graft-versus-host disease in alternative-donor bone marrow transplants.
|
Biol Blood Marrow Transplant
|
2002
|
0.90
|
|
17
|
A revised day +7 predictive score for transplant-related mortality: serum cholinesterase, total protein, blood urea nitrogen, gamma glutamyl transferase, donor type and cell dose.
|
Bone Marrow Transplant
|
2003
|
0.88
|
|
18
|
Risk factors for enterococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients.
|
Transpl Infect Dis
|
2010
|
0.87
|
|
19
|
Improved outcome in young adults with de novo acute myeloid leukemia in first remission, undergoing an allogeneic bone marrow transplant.
|
Bone Marrow Transplant
|
2007
|
0.86
|
|
20
|
Outcome of patients activating an unrelated donor search: the impact of transplant with reduced intensity conditioning in a large cohort of consecutive high-risk patients.
|
Leukemia
|
2012
|
0.86
|
|
21
|
Factors predicting response and graft-versus-host disease after donor lymphocyte infusions: a study on 593 infusions.
|
Bone Marrow Transplant
|
2003
|
0.85
|
|
22
|
Increased risk of leukemia relapse with high dose cyclosporine after allogeneic marrow transplantation for acute leukemia: 10 year follow-up of a randomized study.
|
Blood
|
2001
|
0.84
|
|
23
|
Allogeneic hemopoietic stem cell transplants for patients with relapsed acute leukemia: long-term outcome.
|
Bone Marrow Transplant
|
2007
|
0.84
|
|
24
|
Progenitor cells trapped in marrow filters can reduce GvHD and transplant mortality.
|
Bone Marrow Transplant
|
2006
|
0.84
|
|
25
|
Foscarnet prophylaxis of cytomegalovirus infections in patients undergoing allogeneic bone marrow transplantation (BMT): a dose-finding study.
|
Bone Marrow Transplant
|
2000
|
0.84
|
|
26
|
Allogeneic hemopoietic stem cell transplantation for patients with high risk acute lymphoblastic leukemia: favorable impact of chronic graft-versus-host disease on survival and relapse.
|
Haematologica
|
1998
|
0.83
|
|
27
|
Thiotepa cyclophosphamide followed by granulocyte colony-stimulating factor mobilized allogeneic peripheral blood cells in adults with advanced leukemia.
|
Blood
|
1996
|
0.83
|
|
28
|
CMV-antigenemia after allogeneic bone marrow transplantation: correlation of CMV-antigen positive cell numbers with transplant-related mortality.
|
Bone Marrow Transplant
|
1995
|
0.81
|
|
29
|
Donor lymphocyte infusions (DLI) in patients with chronic myeloid leukemia following allogeneic bone marrow transplantation.
|
Bone Marrow Transplant
|
1997
|
0.81
|
|
30
|
Severe aplastic anemia (SAA): response to cyclosporin A (CyA) in vivo and in vitro.
|
Eur J Haematol
|
1991
|
0.80
|
|
31
|
Long term results of interferon treatment in hairy cell leukemia. Italian Cooperative Group of Hairy Cell Leukemia (ICGHCL).
|
Leuk Lymphoma
|
1994
|
0.80
|
|
32
|
A randomized trial of high dose polyvalent intravenous immunoglobulin (HDIgG) vs. Cytomegalovirus (CMV) hyperimmune IgG in allogeneic hemopoietic stem cell transplants (HSCT).
|
Haematologica
|
1998
|
0.80
|
|
33
|
Low transplant mortality in allogeneic bone marrow transplantation for acute myeloid leukemia: a randomized study of low-dose cyclosporin versus low-dose cyclosporin and low-dose methotrexate.
|
Blood
|
1998
|
0.79
|
|
34
|
Allogeneic bone marrow or peripheral blood cell transplants in adults with hematologic malignancies: a single-center experience.
|
Exp Hematol
|
1998
|
0.78
|
|
35
|
Multivariate analysis of risk factors for survival and relapse in chronic granulocytic leukemia following allogeneic marrow transplantation: impact of disease related variables (Sokal score).
|
Bone Marrow Transplant
|
1993
|
0.78
|
|
36
|
Unrelated donor marrow transplantation: an update of the experience of the Italian Bone Marrow Group (GITMO).
|
Haematologica
|
2001
|
0.78
|
|
37
|
The combined effect of total body irradiation (TBI) and cyclosporin A (CyA) on the risk of relapse in patients with acute myeloid leukaemia undergoing allogeneic bone marrow transplantation.
|
Br J Haematol
|
2000
|
0.78
|
|
38
|
Serum cholinesterase is an early and sensitive marker of graft-versus host-disease (GVHD) and transplant-related mortality (TRM).
|
Bone Marrow Transplant
|
2001
|
0.78
|
|
39
|
Thiotepa-based reduced intensity conditioning regimen: a 10 year follow up.
|
Bone Marrow Transplant
|
2007
|
0.77
|
|
40
|
Early predictors of transplant-related mortality (TRM) after allogeneic bone marrow transplants (BMT): blood urea nitrogen (BUN) and bilirubin.
|
Bone Marrow Transplant
|
1999
|
0.77
|
|
41
|
Forscarnet vs ganciclovir for cytomegalovirus (CMV) antigenemia after allogeneic hemopoietic stem cell transplantation (HSCT): a randomised study.
|
Bone Marrow Transplant
|
1998
|
0.77
|
|
42
|
Impact of marrow unrelated donor search duration on outcome of children with acute lymphoblastic leukemia in second remission.
|
Bone Marrow Transplant
|
2003
|
0.76
|
|
43
|
Cyclic sex hormone replacement therapy in women undergoing allogeneic bone marrow transplantation: aims and results.
|
Bone Marrow Transplant
|
1991
|
0.76
|
|
44
|
The dose of total body irradiation (TBI), and GvHD prophilaxis have a crucial role on relapse risk and survival after BMT for leukaemia.
|
Bone Marrow Transplant
|
1991
|
0.76
|
|
45
|
Combined foscarnet -ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation (Hsct).
|
Bone Marrow Transplant
|
1996
|
0.76
|
|
46
|
Failure of autologous stem cell transplantation in refractory thrombocytopenic purpura.
|
Bone Marrow Transplant
|
1998
|
0.76
|
|
47
|
Long-term results of alpha interferon as initial therapy and splenectomy as consolidation therapy in patients with hairy cell leukemia. Final report from the Italian Cooperative Group for HCL.
|
Ann Oncol
|
1994
|
0.76
|
|
48
|
Human lymphoblastoid interferon for hairy cell leukemia: results from the Italian Cooperative Group.
|
Leukemia
|
1987
|
0.75
|
|
49
|
Combined foscarnet-ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation.
|
Transplantation
|
1996
|
0.75
|
|
50
|
Hairy cell leukemia: splenectomy after alpha-interferon therapy.
|
Blood
|
1992
|
0.75
|
|
51
|
Human lymphoblastoid alpha-interferon for hairy cell leukemia. An update of the Italian Cooperative Group.
|
Bone Marrow Transplant
|
1989
|
0.75
|
|
52
|
Low-dose fractionated total body irradiation (TBI) adversely affects prognosis of patients with leukemia receiving an HLA-matched allogeneic bone marrow transplant from an unrelated donor (UD-BMT).
|
Bone Marrow Transplant
|
2002
|
0.75
|
|
53
|
Bone marrow transplantation from unrelated donors: the Italian experience. GITMO, AIEOP and IBMDR.
|
Bone Marrow Transplant
|
1993
|
0.75
|
|
54
|
Unrelated donor marrow transplantation: initial experience of the Italian bone marrow transplant group (GITMO).
|
Bone Marrow Transplant
|
1996
|
0.75
|
|
55
|
Splenectomy after initial therapy with alpha-IFN in patients with hairy-cell leukemia (HCL): a multi-center study by the Italian Cooperative Group for HCL. Preliminary results.
|
Eur J Haematol Suppl
|
1990
|
0.75
|
|
56
|
Changes in lung volumes and airway responsiveness following haematopoietic stem cell transplantation.
|
Eur Respir J
|
2008
|
0.75
|
|
57
|
Allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission: the effect of FAB classification and GVHD prophylaxis.
|
Bone Marrow Transplant
|
1994
|
0.75
|
|
58
|
Successful treatment of T-hairy cell leukemia with lymphoblastoid-interferon.
|
J Exp Pathol
|
1987
|
0.75
|
|
59
|
Cyclosporin A and chronic graft versus host disease.
|
Bone Marrow Transplant
|
1990
|
0.75
|
|
60
|
Bone marrow transplantation for leukaemia: the role of total body irradiation, graft vs host disease, and haemopoietic chimerism.
|
Bone Marrow Transplant
|
1989
|
0.75
|
|
61
|
Unrelated donor marrow transplantation for chronic myelogenous leukaemia.
|
Br J Haematol
|
1998
|
0.75
|
|
62
|
Late complications of allogeneic bone marrow transplantation.
|
Med Oncol Tumor Pharmacother
|
1991
|
0.75
|
|
63
|
[Hairy-cell leukemia].
|
Recenti Prog Med
|
1993
|
0.75
|
|
64
|
Unrelated donor marrow transplantation: an update of the experience of the Italian Bone Marrow Transplant Group (GITMO).
|
Haematologica
|
2000
|
0.75
|
|
65
|
Hairy cell leukemia. A therapeutical update.
|
Haematologica
|
1989
|
0.75
|
|
66
|
Factors influencing remission post-BMT in patients with acute and chronic leukemia prepared with cyclophosphamide and total body irradiation (TBI).
|
Bone Marrow Transplant
|
1991
|
0.75
|
|
67
|
Patterns of relapse after bone marrow transplantation for chronic myeloid leukaemia.
|
Bone Marrow Transplant
|
1991
|
0.75
|
|
68
|
Improved results in marrow transplantation from unrelated donors. Genoa BMT Group.
|
Haematologica
|
1999
|
0.75
|
|
69
|
Should alpha interferon be used as primary treatment for hairy cell leukemia? Italian Cooperative Group for Hairy Cell Leukemia.
|
Leuk Res
|
1991
|
0.75
|
|
70
|
[Allogeneic bone marrow transplantation in acute and chronic myeloid leukemia: role of conditioning and of graft-versus-host disease in the long-term maintenance of remission].
|
Haematologica
|
1989
|
0.75
|
|
71
|
Allogeneic bone marrow transplantation versus chemotherapy for childhood acute lymphoblastic leukemia in second remission: an update.
|
Bone Marrow Transplant
|
1990
|
0.75
|
|
72
|
Transplantation of HLA-mismatched CD34+ selected cells in patients with advanced malignancies: severe immunodeficiency and related complications.
|
Br J Haematol
|
1997
|
0.75
|
|
73
|
Hairy cell leukemia: the Italian Cooperative Group experience.
|
Leukemia
|
1992
|
0.75
|